查詢結果分析
來源資料
相關文獻
- 2018年美國糖尿病學會針對糖尿病腎病變之標準治療建議
- 伴有糖尿病腎病變的老年患者使用Diclofenac造成的急性腎損傷案例報告
- 2018年美國糖尿病學會針對糖尿病合併血脂異常之標準治療建議
- 美國糖尿病學會針對糖尿病兒童和青少年之醫療照護標準新建議
- 2018年美國糖尿病學會針對糖尿病合併高血壓之標準治療建議
- 2021年美國糖尿病學會針對糖尿病合併血脂異常之標準治療建議
- 大黃及其有效成分(Emodin)對糖尿病腎病變治療效果之研究
- Effects of Dietary Protein on Urinary Epidermal Growth Factor and Renal Hypertrophy in Diabetic Rats
- The Initial Status and Outcomes of Newly Diagnosed Uremic Patients in Southern Taiwan
- 糖尿病腎病變
頁籤選單縮合
題名 | 2018年美國糖尿病學會針對糖尿病腎病變之標準治療建議=Diabetic Kidney Disease Care: Standards of Medical Care in Diabetes--2018 |
---|---|
作者 | 郝立智; 張雅椅; 楊純宜; 吳鈴鳳; 徐仁愛; 林玉萍; 譚宏斌; 奚明德; 王志龍; 吳明瑞; Hao, Lyh-jyh; Chang, Ya-yi; Yang, Chwen-yi; Wu, Ling-feng; Hsu, Jen-ai; Lin, Yu-ping; Tan, Hung-pin; Shi, Ming-der; Wang, Jue-long; Wu, Ming-jui; |
期刊 | 內科學誌 |
出版日期 | 20180800 |
卷期 | 29:4 2018.08[民107.08] |
頁次 | 頁250-261 |
分類號 | 415.6685 |
語文 | chi |
關鍵詞 | 糖尿病腎病變; 急性腎損傷; 美國糖尿病學會; 動脈粥樣硬化性心血管疾病; Diabetic kidney disease; DKD; Acute kidney injury; AKI; American Diabetes Association; ADA; Atherosclerotic cardiovascular disease; ASCVD; |
中文摘要 | 本次標準治療建議增加了一張新表格(表一),該表格結合了慢性腎臟疾病分期和每個階段適當的腎臟相關照護的信息。新的表二列出了慢性腎臟疾病併發症的描述以及相關的醫學和實驗室評估。包括了一個關於急性腎損傷的新章節。討論了具體的降血糖藥物對腎臟疾病的延遲和進展的影響,並參考了最近以檢測腎功能之效應作為次要結果的CVOT試驗(Cardiovascular Outcome Trial)。 |
英文摘要 | A new table (Table 1) was added in this standard medical care, that combines information on staging chronic kidney disease and the appropriate kidney-related care for each stage. A new Table 2 was included describing the complications of chronic kidney disease and related medical and laboratory evaluations. A new section on acute kidney injury was included. The effect of specific glucose-lowering medications on the delay and progression of kidney disease was discussed, with reference to recent CVOT trials that examined kidney effects as secondary outcomes. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。